AHK-CU 100mg

AHK-CU 100mg

AHK-CU 100mg is a copper-binding tripeptide product intended for scientific and research consideration. The compound, also described as an alanine-histidine-lysine copper complex, belongs to the broader group of copper-peptide compounds studied in laboratory and preclinical research.

This product listing specifies a quantity of 100mg. The brand, physical format, purity, storage conditions, packaging details, batch information and product-specific documentation have not been provided. These details should therefore be confirmed from the actual product label and supplier documentation before publication or purchase.

AHK-Cu has a relatively limited direct scientific evidence base compared with some other copper peptides. Researchers interested in this compound may explore its chemical characteristics, interactions with biological systems and its role in experimental models. Published research has included laboratory and ex vivo investigation involving human hair follicles and dermal papilla cells, although such findings should not be interpreted as established benefits or outcomes in humans.

Product Overview

AHK-Cu is generally described as a copper complex of the tripeptide L-alanyl-L-histidyl-L-lysine. Its three-amino-acid sequence distinguishes it from other copper peptides, including GHK-Cu.

The AHK-CU 100mg listing provides a clearly stated quantity for researchers seeking a larger-quantity product option. However, the exact physical presentation of this particular item has not been independently confirmed from the information supplied. It should not be assumed to be supplied in any specific vial, powder or other format unless that information is visible on the actual product packaging.

For researchers, accurate identification of the compound and clear product specifications are important. Scientific literature on AHK-Cu is substantially narrower than the wider literature on related copper peptides, so compound-specific evidence should be distinguished from information relating to other substances.

Why Choose This Product

When evaluating a research compound, clear and accurate product information is more valuable than unsupported claims. The principal confirmed characteristic of this listing is the stated 100mg quantity and its identification as AHK-Cu.

Before selecting a research product, customers should consider the information available from the supplier, including:

• Clear identification of the compound
• The stated quantity
• The actual product format and packaging
• Any available batch-specific documentation
• Product traceability where documentation is provided
• Appropriate intended-use labelling
• Accessible customer support for product enquiries

No purity percentage, manufacturer certification, independent testing result or other quality claim is made here because such information has not been provided for this specific listing. Transparent product presentation allows researchers to make purchasing decisions based on verifiable information rather than assumptions.

Research Information

AHK-Cu is a tripeptide-copper complex composed of the amino-acid sequence alanine, histidine and lysine associated with copper. It is structurally distinct from GHK-Cu, and evidence relating to GHK-Cu should not automatically be presented as evidence for AHK-Cu.

A published study indexed by PubMed examined AHK-Cu in ex vivo human hair follicles and cultured dermal papilla cells. This work provides a specific example of the types of laboratory systems in which the compound has been investigated. However, findings from cell culture and ex vivo research do not establish clinical effects or proven outcomes in humans.

The limited direct evidence surrounding AHK-Cu makes careful scientific interpretation especially important. Researchers reviewing the compound may wish to consult the original published literature and distinguish AHK-Cu-specific findings from broader discussions of copper peptides.

For wider scientific literature searches, PubMed provides access to the published record and related scientific references.

Quality and Trust

Trustworthy product information should clearly separate verified specifications from information that has not been confirmed. For this AHK-CU 100mg listing, no batch-specific Certificate of Analysis, independent laboratory result, purity percentage or manufacturer documentation has been supplied.

If product-specific documentation becomes available, it should be evaluated for relevance to the exact compound and batch offered. Any certificate, analytical result or specification should correspond to the actual product rather than being presented as a general claim.

Peptide Depot should also ensure that the product page accurately reflects the item’s actual intended purpose and available documentation. Clear specifications, accurate labelling and accessible support can help customers make informed purchasing decisions.

Buying With Confidence

Customers researching specialised compounds should evaluate suppliers carefully and review the information available for the exact product they are considering. Useful factors include transparent specifications, clear product labelling, available documentation, customer support and clear ordering and shipping information.

In the United Kingdom, product presentation and intended purpose can be relevant when determining whether a product falls within the definition of a medicine. The MHRA’s guidance on borderline products explains how products may be assessed according to their presentation and other relevant factors. Product descriptions should therefore avoid unsupported medicinal or therapeutic claims.

Customers should review the current information published on the official Peptide Depot website before ordering and contact the supplier directly with questions about product specifications or available documentation.

Important Research-Use Notice

AHK-CU 100mg should be presented according to its actual product status and intended purpose. Where supplied as a research product, it should be clearly identified as for research purposes only and should not be presented as a medicine, treatment or approved therapeutic product. This page does not provide dosing or instructions for human administration.